Minimally invasive versus conventional sternotomy for Mitral valve repair: protocol for a multicentre randomised controlled trial (UK Mini Mitral)

Author:

Maier Rebecca HORCID,Kasim Adetayo SORCID,Zacharias Joseph,Vale LukeORCID,Graham Richard,Walker Antony,Laskawski Grzegorz,Deshpande Ranjit,Goodwin Andrew,Kendall Simon,Murphy Gavin JORCID,Zamvar VipinORCID,Pessotto Renzo,Lloyd Clinton,Dalrymple-Hay Malcolm,Casula Roberto,Vohra Hunaid A,Ciulli Franco,Caputo MassimoORCID,Stoica Serban,Baghai Max,Niranjan Gunaratnam,Punjabi Prakash P,Wendler Olaf,Marsay Leanne,Fernandez-Garcia CristinaORCID,Modi Paul,Kirmani Bilal H,Pullan Mark D,Muir Andrew D,Pousios Dimitrios,Hancock Helen CORCID,Akowuah EnochORCID

Abstract

IntroductionNumbers of patients undergoing mitral valve repair (MVr) surgery for severe mitral regurgitation have grown and will continue to rise. MVr is routinely performed via median sternotomy; however, there is a move towards less invasive surgical approaches.There is debate within the clinical and National Health Service (NHS) commissioning community about widespread adoption of minimally invasive MVr surgery in the absence of robust research evidence; implementation requires investment in staff and infrastructure.The UK Mini Mitral trial will provide definitive evidence comparing patient, NHS and clinical outcomes in adult patients undergoing MVr surgery. It will establish the best surgical approach for MVr, setting a standard against which emerging percutaneous techniques can be measured. Findings will inform optimisation of cost-effective practice.Methods and analysisUK Mini Mitral is a multicentre, expertise based randomised controlled trial of minimally invasive thoracoscopically guided right minithoracotomy versus conventional sternotomy for MVr. The trial is taking place in NHS cardiothoracic centres in the UK with established minimally invasive mitral valve surgery programmes. In each centre, consenting and eligible patients are randomised to receive surgery performed by consultant surgeons who meet protocol-defined surgical expertise criteria. Patients are followed for 1 year, and consent to longer term follow-up.Primary outcome is physical functioning 12 weeks following surgery, measured by change in Short Form Health Survey (SF-36v2) physical functioning scale. Early and 1 year echo data will be reported by a core laboratory. Estimates of key clinical and health economic outcomes will be reported up to 5 years.The primary economic outcome is cost effectiveness, measured as incremental cost per quality-adjusted life year gained over 52 weeks following index surgery.Ethics and disseminationA favourable opinion was given by Wales REC 6 (16/WA/0156). Trial findings will be disseminated to patients, clinicians, commissioning groups and through peer reviewed publication.Trial registration numberISRCTN13930454.

Funder

Health Technology Assessment Programme

Publisher

BMJ

Subject

General Medicine

Reference52 articles.

1. Long-Term outcomes of mitral valve repair versus replacement for degenerative disease: a systematic review;McNeely;Curr Cardiol Rev,2015

2. Mitral valve repair versus replacement in the elderly: Short-term and long-term outcomes

3. Concomitant aortic and mitral surgery: to replace or repair the mitral valve?;Coutinho;J Thorac Cardiovasc Surg,2014

4. Effect of mitral valve repair versus replacement on left ventricular rotational deformation: a study with speckle tracking echocardiography;Candan;J Heart Valve Dis,2013

5. Mitral valve repair versus replacement in the elderly population;Markar;J Heart Valve Dis,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3